Search
for
Sort by
Research 241–270 of 1000+
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Treatment options for polycystic ovary syndrome
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Alopecia Universalis Successfully Treated With Adalimumab
- Premature aging syndromes: From patients to mechanism
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Application of Baricitinib in Dermatology
- Alopecia areata – Current understanding and management
- Aromatase inhibition by letrozole attenuates kainic acid-induced seizures but not neurotoxicity in mice
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Alopecia universalis unter Adalimumabtherapie bei einer Patientin mit rheumatoider Arthritis
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Dysregulated behaviour of hair follicle stem cells triggers alopecia and provides potential therapeutic targets
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- TRPV3 Ion Channel: From Gene to Pharmacology
- Dermatologic Adverse Events from Cancer Treatments
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs